Tiefenbacher Group International Social Day

Tiefenbacher Group - Collage of three group photos showing diverse people in blue Tiefenbacher Group shirts smiling and posing at International Social Day events in India, Cyprus, and Germany—a family-owned pharmaceutical company known for generic medicines manufacturing.

TIEFENBACHER SOCIAL DAY GOES GLOBALLast week marked a very special moment for all of us at Tiefenbacher Group. It was our very first international SocialDay. Across all our locations, from Hamburg to Hyderabad to Nicosia, hundreds of colleagues stepped out of their daily routines to support meaningful social, environmental, and community initiatives. Whether helping at […]

Tiefenbacher Group’s New Packaging Line in Cyprus

Tiefenbacher Group - A modern packaging machine for pharmaceutical healthcare solutions operates in a clean, well-lit factory with gray floors, white ceilings, transparent panels, conveyor belts, and colored indicator lights.

Tiefenbacher Group is expanding the production capacity with a new packaging line in Cyprus to make medicines more affordable and available.At Tiefenbacher Group, we believe that access to affordable, high-quality medicine should never be limited by production capacity. That’s why we’re thrilled to share that this new addition is a key step in enhancing capabilities […]

Tiefenbacher Group celebrating Delorbis 10th Birthday

Tiefenbacher Group - A three-tier cake with "10" and "2014-2024" decorations celebrates Delorbis, a family-owned pharmaceutical company, on its 10-year anniversary. Fireworks, balloons, and a Delorbis backdrop appear in event photos with the Tiefenbacher Group logo.

Tiefenbacher Group celebrating a Decade of Excellence:Tiefenbacher Group is delighted to announce a significant milestone in the journey of Delorbis Pharmaceuticals Ltd, our state-of-the-art manufacturing site and branded business on the beautiful island of Cyprus. This year, Delorbis celebrates its 10th anniversary, marking a decade of European excellence and meaningful contributions to the pharmaceutical industry. […]